There are no or limited amount of data from the use of mometasone furoate in pregnant women. As with other nasal corticosteroid preparations, Mometasone Furoate Aqueous Nasal Spray should not be used in pregnancy unless the potential benefit to the mother justifies any potential risk to the mother, foetus or infant.
Infants born of mothers who received corticosteroids during pregnancy should be observed carefully for hypoadrenalism.
It is not known if mometasone furoate is excreted in human milk. Because other corticosteroids are excreted in human milk, caution should be used when Mometasone Furoate Aqueous Nasal Spray is administered to nursing women.